| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:BMS-737 CAS:1356053-63-8 Package:50mg;10mg
|
|
| | 5-[1-(4-Fluorophenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-4-pyrimidinamine Basic information |
| | 5-[1-(4-Fluorophenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-4-pyrimidinamine Chemical Properties |
| Boiling point | 487.3±45.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 3.76±0.10(Predicted) |
| | 5-[1-(4-Fluorophenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-4-pyrimidinamine Usage And Synthesis |
| Uses | BMS-737 (compound 33) is a non-steroidal, reversible small molecule inhibitor. BMS-737 exhibits 11-fold selectivity for CYP17 lyase over CYP17 hydroxylase. BMS-737 is designed to inhibit castration-resistant prostate cancer (CRPC) and significantly reduces testosterone levels without significant effects on orrodermal hormone and glucocorticoid levels[1]. | | References | [1] Padmakar Darne C, et al. The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer. Bioorg Med Chem Lett. 2022 Nov 1;75:128951. DOI:10.1016/j.bmcl.2022.128951 |
| | 5-[1-(4-Fluorophenyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-4-pyrimidinamine Preparation Products And Raw materials |
|